Related Experiment Video

Updated: May 29, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

The relationship between cerebrovascular complications and previously established use of antiplatelet therapy in

Ulrika Snygg-Martin1, Rasmus Vedby Rasmussen, Christian Hassager

  • 1Department of Infectious Diseases, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden. ulrika.snygg-martin@gu.se

Scandinavian Journal of Infectious Diseases
|September 16, 2011
PubMed

Insights

Previously established antiplatelet therapy did not reduce cerebrovascular complications in infective endocarditis (IE). While univariate analysis showed higher mortality, multivariable modeling found no significant association, suggesting antiplatelet therapy is not linked to worse outcomes in IE patients.

Area of Science:

  • Cardiology
  • Neurology
  • Infectious Diseases

Background:

  • Cerebrovascular complications (CVC) are frequent in infective endocarditis (IE).
  • Current treatments for IE-related CVC include antibiotics and, in select cases, cardiac surgery.
  • The role of antiplatelet therapy in preventing IE-related CVC remains unclear.

Purpose of the Study:

  • To investigate the influence of pre-existing antiplatelet therapy on the incidence of CVC in patients with IE.
  • To assess the impact of antiplatelet therapy on mortality rates in IE patients.

Main Methods:

  • Prospective cohort study conducted in Sweden and Denmark.
  • Logistic regression models were used to analyze data from 684 left-sided definite IE episodes.
  • Patients on antiplatelet therapy were compared to those not on therapy regarding CVC incidence and mortality.

Main Results:

  • No significant difference in CVC rates was observed between patients on antiplatelet therapy (23.6%) and those not (25.0%).
  • Ischemic stroke was the most common CVC (16.8%), with no correlation to antiplatelet use.
  • Unadjusted mortality was higher in patients on antiplatelet therapy, but this association disappeared after multivariable adjustment.

Conclusions:

  • Pre-existing antiplatelet therapy does not appear to reduce the incidence of symptomatic CVC in IE patients.
  • While initial analysis suggested higher mortality with antiplatelet therapy, multivariable modeling indicated no significant association.
  • The findings suggest that established antiplatelet therapy may not negatively impact outcomes in IE patients.
Abstract

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...